Evidence map›Paper›PMID 32983999›Full record

ArticleFrontiers in oncology2020

WHO Grade I Meningioma Recurrence: Identifying High Risk Patients Using Histopathological Features and the MIB-1 Index.

Alexander F Haddad, Jacob S Young, Ishan Kanungo, Sweta Sudhir, Jia-Shu Chen, David R Raleigh, Stephen T Magill, Michael W McDermott, Manish K Aghi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Paediatric meningiomas: a multi-centre case series of 27 patients.Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery · 2024
    Article
  16. Article
  17. MRI features and tumor-infiltrating CD8 + T cells-based nomogram for predicting meningioma recurrence risk.Cancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Alexander F HaddadDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Jacob S YoungDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Ishan KanungoDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Sweta SudhirDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Jia-Shu ChenDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
David R RaleighDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Stephen T MagillDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Michael W McDermottMiami Neuroscience Institute, South Miami, FL, United States.
Manish K AghiDepartment of Neurological Surgery, University of California, San Francisco, San Francisco, CA, United States.
Neurological Surgery · USUniversity of California, San Francisco · US

Funding

Tumor cell and microenvironment changes causing antiangiogenic therapy resistanceR01NS079697 · NINDS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGHI, MANISH · 2013 to 2021
$3.2M
Modeling and druggable-genome screening of glioblastoma invasion using regional biopsy-guided biomaterials systemsR01CA227136 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AGHI, MANISH · 2018 to 2022
$2.2M
NCI NIH HHS R01 CA227136NINDS NIH HHS R01 NS079697
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

benignearly recurrencelate recurrencemeningiomaMIB-1recurrenceWHO grade I

Identifiers

PMID32983999
PMCPMC7483477
OpenAlexW3080842140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.